Case Report: Case series: association between blood concentration and side effects of sotorasib

INTRODUCTION: Sotorasib is a crucial therapeutic agent for patients with non-small cell lung cancer (NSCLC) harboring the KRAS p.G12C mutation. Despite its efficacy, the relationship between blood sotorasib concentrations and side effects remains largely unexplored. METHODS: This study enrolled five...

Descripción completa

Detalles Bibliográficos
Autores principales: Shigaki, Ryota, Yoshida, Ryohei, Yagita, Akari, Nagasue, Kazunori, Naraoka, Taeka, Nitanai, Kiichi, Yanada, Hiraku, Tenma, Toshiyuki, Kida, Ryotaro, Umekage, Yasuhiro, Mori, Chie, Minami, Yoshinori, Sato, Hideki, Iwayama, Kuninori, Hashino, Yasuhisa, Fukudo, Masahide, Sasaki, Takaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690615/
https://www.ncbi.nlm.nih.gov/pubmed/38044989
http://dx.doi.org/10.3389/fonc.2023.1269991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690615/
https://www.ncbi.nlm.nih.gov/pubmed/38044989
http://dx.doi.org/10.3389/fonc.2023.1269991

Ejemplares similares